Head/Neck Cancer

Top Story

Use of NSAIDs improves survival in head and neck cancer subset

Use of NSAIDs improves survival in head and neck cancer subset
March 25, 2019

Immunotherapy likely to become standard for recurrent/metastatic head and neck cancers

March 22, 2019
The standard treatment for patients with recurrent or metastatic head and neck cancers is expected to change from chemotherapy to immunotherapy based on results of…
Meeting News

Cisplatin superior to cetuximab for locally advanced head and neck cancer

March 22, 2019
NEW YORK — Cisplatin appears to be superior to cetuximab for patients with locally advanced head and neck cancer regardless of HPV status, according to a presenter…
In the Journals Plus

Chemoradiotherapy may confer survival benefit in sinonasal undifferentiated carcinoma

March 15, 2019
Patients with sinonasal undifferentiated carcinoma who responded well to induction chemotherapy had better survival outcomes with definitive concurrent chemoradiotherapy…
More Headlines »
CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Video
Meeting News

VIDEO: Anti-CD47 fusion protein well tolerated by patients with solid tumors, non-Hodgkin lymphoma

June 24, 2018
More »